Rep. Kevin Hern sold Biogen (BIIB)
Rep. Kevin Hern (R-OK-1) · $1K–$15K · traded Aug 18, 2026
- Transaction
- Sold
- Amount
- $1K–$15K
- Owner
- Not stated
- Traded
- Aug 18, 2026
- Disclosed
- Sep 1, 2026
- Days to disclose
- 14
- Asset type
- Stock
- As filed
- Biogen Inc. - Common Stock
- Industry
- Drug Manufacturers - General · Healthcare
Other trades in this filing
All of Hern's trades →- Sep 1, 2026$15K–$50K
$15K–$50K · Traded Aug 24, 2026 · disclosed Sep 1, 2026 · Joint
Traded 8 days before earnings - Sep 1, 2026$1K–$15K
$1K–$15K · Traded Aug 24, 2026 · disclosed Sep 1, 2026 · Joint
- Sep 1, 2026$50K–$100K
Sold The Procter & Gamble Company PG
$50K–$100K · Traded Aug 24, 2026 · disclosed Sep 1, 2026 · Joint
- Sep 1, 2026$100K–$250K
Bought CANADIAN CNTY OKLA EDL FACS AUTH EDL 3.00000% 09/01/2029
$100K–$250K · Traded Aug 24, 2026 · disclosed Sep 1, 2026 · Joint
- Sep 1, 2026$1K–$15K
Sold Marsh & McLennan Companies MRSH
$1K–$15K · Traded Aug 24, 2026 · disclosed Sep 1, 2026 · Joint
- Sep 1, 2026$50K–$100K
Sold (partial) The Home Depot HD
$50K–$100K · Traded Aug 24, 2026 · disclosed Sep 1, 2026 · Joint
Got $20K from the company’s PAC - Sep 1, 2026$15K–$50K
$15K–$50K · Traded Aug 21, 2026 · disclosed Sep 1, 2026 · Joint
Got $11K from the company’s PAC - Sep 1, 2026$1K–$15K
$1K–$15K · Traded Aug 21, 2026 · disclosed Sep 1, 2026 · Joint
- Sep 1, 2026$1K–$15K
Sold Colgate-Palmolive Company CL
$1K–$15K · Traded Aug 19, 2026 · disclosed Sep 1, 2026 · Joint
- Sep 1, 2026$15K–$50K
$15K–$50K · Traded Aug 19, 2026 · disclosed Sep 1, 2026 · Joint
- Sep 1, 2026$1K–$15K
$1K–$15K · Traded Aug 18, 2026 · disclosed Sep 1, 2026
- Sep 1, 2026$1K–$15K
Sold Anheuser-Busch InBev SA/NV BUD
$1K–$15K · Traded Aug 18, 2026 · disclosed Sep 1, 2026
- Sep 1, 2026$1K–$15K
$1K–$15K · Traded Aug 14, 2026 · disclosed Sep 1, 2026 · Joint
- Sep 1, 2026$1K–$15K
$1K–$15K · Traded Aug 14, 2026 · disclosed Sep 1, 2026 · Joint
- Sep 1, 2026$15K–$50K
$15K–$50K · Traded Aug 14, 2026 · disclosed Sep 1, 2026 · Joint
- Sep 1, 2026$15K–$50K
Sold (partial) ICON Public Limited Company ICLR
$15K–$50K · Traded Aug 14, 2026 · disclosed Sep 1, 2026 · Joint
- Sep 1, 2026$15K–$50K
$15K–$50K · Traded Aug 13, 2026 · disclosed Sep 1, 2026 · Joint
- Sep 1, 2026$1K–$15K
$1K–$15K · Traded Aug 13, 2026 · disclosed Sep 1, 2026 · Joint
- Sep 1, 2026$1K–$15K
$1K–$15K · Traded Aug 13, 2026 · disclosed Sep 1, 2026
- Sep 1, 2026$1K–$15K
$1K–$15K · Traded Aug 13, 2026 · disclosed Sep 1, 2026 · Joint
Recent Congress trades in BIIB
- Oct 7, 2026$1K–$15K
Rep. Maria Elvira Salazar (R-FL-27)
$1K–$15K · Traded Sep 24, 2026 · disclosed Oct 7, 2026
- Oct 7, 2026$1K–$15K
Rep. Ro Khanna (D-CA-17)
$1K–$15K · Traded Sep 11, 2026 · disclosed Oct 7, 2026 · Dependent
- Oct 7, 2026$1K–$15K
Rep. Ro Khanna (D-CA-17)
$1K–$15K · Traded Sep 4, 2026 · disclosed Oct 7, 2026 · Spouse
- Jul 21, 2026$1K–$15K
Sen. Alan Armstrong (R-OK)
$1K–$15K · Traded Mar 27, 2026 · disclosed Jul 21, 2026 · filed 116 days later
Committee overlap: HELP - Jul 7, 2026$15K–$50K
Rep. Maria Elvira Salazar (R-FL-27)
$15K–$50K · Traded Jun 2, 2026 · disclosed Jul 7, 2026
- Jul 2, 2026$1K–$15K
Rep. Gilbert Ray Cisneros, Jr. (D-CA-31)
$1K–$15K · Traded Jun 5, 2026 · disclosed Jul 2, 2026
- Jun 8, 2026$1K–$15K
Rep. Maria Elvira Salazar (R-FL-27)
$1K–$15K · Traded May 12, 2026 · disclosed Jun 8, 2026
- Jun 8, 2026$50K–$100K
Rep. Maria Elvira Salazar (R-FL-27)
$50K–$100K · Traded May 11, 2026 · disclosed Jun 8, 2026
Company context for BIIB
Recent records for the company. These may have been published before or after this trade; compare the dates before drawing a connection.
BIIB: 10-Q financial filing
Filed 10-Q for an event or period dated 2026-09-30. Read the company report for its disclosures.
1 congressional household disclosed purchases in the past 90 days. See the trades
BIIB: Financial results
Filed 8-K for an event or period dated 2026-10-28. Financial results.
1 congressional household disclosed purchases in the past 90 days. See the trades
From a periodic transaction report filed under the STOCK Act. Amounts are the ranges members report. Nothing here is investment advice.